首页> 美国卫生研究院文献>other >Optimization of Cardiovascular Stent against Restenosis: Factorial Design-Based Statistical Analysis of Polymer Coating Conditions
【2h】

Optimization of Cardiovascular Stent against Restenosis: Factorial Design-Based Statistical Analysis of Polymer Coating Conditions

机译:心血管支架再狭窄的优化:聚合物涂层条件为基础的设计阶乘统计分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The objective of this study was to optimize the physicodynamic conditions of polymeric system as a coating substrate for drug eluting stents against restenosis. As Nitric Oxide (NO) has multifunctional activities, such as regulating blood flow and pressure, and influencing thrombus formation, a continuous and spatiotemporal delivery of NO loaded in the polymer based nanoparticles could be a viable option to reduce and prevent restenosis. To identify the most suitable carrier for S-Nitrosoglutathione (GSNO), a NO prodrug, stents were coated with various polymers, such as poly (lactic-co-glycolic acid) (PLGA), polyethylene glycol (PEG) and polycaprolactone (PCL), using solvent evaporation technique. Full factorial design was used to evaluate the effects of the formulation variables in polymer-based stent coatings on the GSNO release rate and weight loss rate. The least square regression model was used for data analysis in the optimization process. The polymer-coated stents were further assessed with Differential scanning calorimetry (DSC), Fourier transform infrared spectroscopy analysis (FTIR), Scanning electron microscopy (SEM) images and platelet adhesion studies. Stents coated with PCL matrix displayed more sustained and controlled drug release profiles than those coated with PLGA and PEG. Stents coated with PCL matrix showed the least platelet adhesion rate. Subsequently, stents coated with PCL matrix were subjected to the further optimization processes for improvement of surface morphology and enhancement of the drug release duration. The results of this study demonstrated that PCL matrix containing GSNO is a promising system for stent surface coating against restenosis.
机译:这项研究的目的是优化聚合物系统的物理动力学条件,将其作为药物洗脱支架抵抗再狭窄的涂层基质。由于一氧化氮(NO)具有多种功能,例如调节血流和压力,并影响血栓形成,因此在聚合物基纳米颗粒中连续和时空递送NO可能是减少和预防再狭窄的可行选择。为了确定最适合S-亚硝基谷胱甘肽(GSNO)的载体(一种NO前药),在支架上涂覆了各种聚合物,例如聚乳酸-乙醇酸共聚物(PLGA),聚乙二醇(PEG)和聚己内酯(PCL) ,采用溶剂蒸发技术。使用全因子设计来评估聚合物基支架涂层中配方变量对GSNO释放速率和失重速率的影响。最小二乘回归模型用于优化过程中的数据分析。用差示扫描量热法(DSC),傅立叶变换红外光谱分析(FTIR),扫描电子显微镜(SEM)图像和血小板粘附研究进一步评估了聚合物涂层的支架。涂有PCL基质的支架比涂有PLGA和PEG的支架显示出更持久和更受控的药物释放曲线。涂有PCL基质的支架显示出最小的血小板粘附率。随后,对涂有PCL基质的支架进行进一步的优化处理,以改善表面形态并延长药物释放时间。这项研究的结果表明,含有GSNO的PCL基质是用于支架表面涂层抗再狭窄的有前途的系统。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号